• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的H2受体抗组胺药对免疫缺陷小鼠体内异种移植的人黑素瘤细胞生长的抑制作用有所不同。

Different h2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice.

作者信息

Szincsák Nora, Hegyesi Hargita, Hunyadi Janos, Falus Andras, Juhász Istvan

机构信息

Department of Dermatology, Debrecen University, Debrecen, Hungary.

出版信息

Cell Biol Int. 2002;26(9):833-6. doi: 10.1016/s1065-6995(02)90934-0.

DOI:10.1016/s1065-6995(02)90934-0
PMID:12377215
Abstract

Melanoma cells and tissues contain considerable amounts of histamine and express histamine receptors, suggesting the existence of autocrine and paracrine regulation by histamine. Our previous in vitro results suggested that histamine elevates melanoma cell growth through the H2 receptor. In this work we show that in vivo tumour proliferation in immunodeficient mice xenotransplanted with a human melanoma cell line is diminished by cimetidine, an H2 receptor antagonist, if combined with a tamoxifen derivate acting on cytochrome p450 molecules (DPPE). Ranitidine, another H2 receptor antagonist, has a weaker inhibitory effect, the kinetics and mechanism of which is probably dissimilar to that of the cimetidine/DPPE mixture.

摘要

黑色素瘤细胞和组织含有大量组胺并表达组胺受体,这表明存在组胺的自分泌和旁分泌调节。我们之前的体外实验结果表明,组胺通过H2受体促进黑色素瘤细胞生长。在本研究中,我们发现,在用人黑色素瘤细胞系异种移植的免疫缺陷小鼠体内,H2受体拮抗剂西咪替丁若与作用于细胞色素p450分子的他莫昔芬衍生物(DPPE)联合使用,可减少肿瘤增殖。另一种H2受体拮抗剂雷尼替丁的抑制作用较弱,其动力学和作用机制可能与西咪替丁/DPPE混合物不同。

相似文献

1
Different h2 receptor antihistamines dissimilarly retard the growth of xenografted human melanoma cells in immunodeficient mice.不同的H2受体抗组胺药对免疫缺陷小鼠体内异种移植的人黑素瘤细胞生长的抑制作用有所不同。
Cell Biol Int. 2002;26(9):833-6. doi: 10.1016/s1065-6995(02)90934-0.
2
Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line.西咪替丁和一种他莫昔芬衍生物可减少用人黑色素瘤细胞系异种移植的SCID小鼠中的肿瘤形成。
Melanoma Res. 2002 Jun;12(3):231-40. doi: 10.1097/00008390-200206000-00006.
3
Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth.雷尼替丁和西咪替丁对人类结肠癌生长的体外和体内作用存在差异。
Br J Cancer. 1996 Apr;73(7):872-6. doi: 10.1038/bjc.1996.155.
4
Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.依溴替丁、雷尼替丁和西咪替丁对组胺H1和H2受体特异性结合的作用。
Arzneimittelforschung. 1997 Apr;47(4A):447-9.
5
The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture.
Biochem Biophys Res Commun. 1991 May 31;177(1):545-50. doi: 10.1016/0006-291x(91)92018-f.
6
Alteration of tyrosinase activity in human melanocytes and melanoma cells by histamine H2 and H3 ligands.组胺H2和H3配体对人黑素细胞和黑色素瘤细胞中酪氨酸酶活性的影响。
Melanoma Res. 1994 Dec;4(6):359-64. doi: 10.1097/00008390-199412000-00003.
7
Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.H2拮抗剂对豚鼠自主搏动心房中组胺或二甲双胍刺激的H2受体的作用机制。
Agents Actions. 1990 Aug;31(1-2):23-35. doi: 10.1007/BF02003217.
8
Demonstration of histamine H2 receptors on human melanoma cells.人黑色素瘤细胞上组胺H2受体的证明
Biochem Biophys Res Commun. 1988 Feb 29;151(1):518-23. doi: 10.1016/0006-291x(88)90624-9.
9
The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines.H2拮抗剂对人结肠癌细胞系增殖和凋亡的影响。
Dig Dis Sci. 2004 Oct;49(10):1634-40. doi: 10.1023/b:ddas.0000043377.30075.ac.
10
Pharmacology of histamine H2 receptor antagonists in the human gastric cancer cell line HGT-1. Structure-activity relationship of isocytosine-furan and imidazole derivatives related to cimetidine.组胺H2受体拮抗剂在人胃癌细胞系HGT-1中的药理学。与西咪替丁相关的异胞嘧啶-呋喃和咪唑衍生物的构效关系。
Biochem Pharmacol. 1986 Jun 1;35(11):1825-34. doi: 10.1016/0006-2952(86)90299-6.

引用本文的文献

1
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.肿瘤学中药物的重新利用(ReDO)——西咪替丁作为一种抗癌药物
Ecancermedicalscience. 2014 Nov 26;8:485. doi: 10.3332/ecancer.2014.485. eCollection 2014.
2
Histamine receptors and cancer pharmacology.组胺受体与癌症药理学。
Br J Pharmacol. 2010 Oct;161(4):755-67. doi: 10.1111/j.1476-5381.2010.00961.x.
3
Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial.
围手术期给予西咪替丁可促进胃肠道癌患者外周血淋巴细胞及肿瘤浸润淋巴细胞:一项随机对照临床试验的结果
World J Gastroenterol. 2004 Jan;10(1):136-42. doi: 10.3748/wjg.v10.i1.136.